Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study.

submitted by: WentzMR

Dr. Sahil Khanna, Gastroenterology Fellow at Mayo Clinic in Rochester, MN, discusses his article appearing in the July 2012 issue of Mayo Clinic Proceedings on the effects of medications, including proton pump inhibitors (PPI) and histamine type 2 (H2) blockers, on outcomes in patients with Clostridium difficile infection (CDI) in a population-based cohort. Available at: